Browsing Tag
Japan
223 posts
Aflac (NYSE: AFL) Q4 2025 earnings: What declining revenues and rising dividends reveal about strategy
Aflac’s Q4 2025 earnings saw declining revenues but rising dividends and capital return. Find out what it signals for Aflac’s Japan and U.S. business in 2026.
Bain Capital takes control of FineToday Holdings in private equity-to-PE deal
Bain Capital acquires FineToday from CVC Capital Partners, signaling a new chapter for the Japan-based personal care brand. Find out what this deal means.
Robert Walters (LON: RWA) Q4 2025 results: UK hiring rebounds, but Europe and Asia lag amid restructuring push
Robert Walters grew UK hiring by 25% in Q4 2025, but Europe remains challenged. Find out what this means for its 2026 strategy and global recruitment trends.
Tired of tourist traps in Japan? Tabelog’s new app could change the game
Tabelog now lets travelers book real Japanese restaurants in English, Chinese, and Korean. Find out how Kakaku.com is reshaping tourism through food.
SEMIFIVE accelerates global AI chip expansion with Japan subsidiary and new design wins
Discover how SEMIFIVE is reshaping global AI chip design with a new Japan base and project wins—find out what’s driving its rapid expansion and investor buzz.
7.6 magnitude earthquake shakes northeast Japan as tsunami warning triggers mass evacuations
A 7.6 magnitude earthquake shook northeast Japan, prompting tsunami warnings and mass evacuations. Find out how disaster systems responded and what’s next for coastal resilience.
Is Japan’s chip revival strategy finally paying off? A closer look at subsidies, talent, and national resilience
Is Japan’s chip comeback real? Explore how subsidies, fabs, and global partnerships are reshaping its semiconductor industry for the AI age.
Ōita wildfire destroys 170 homes in Japan’s Kyushu region: What caused the fast-moving blaze?
Discover how the fire in Ōita, Japan destroyed 170 homes and forced mass evacuations—and what it means for wildfire risk and urban resilience.
Will orforglipron turn Eli Lilly into the king of GLP-1s? The FDA decision that could change obesity care
Eli Lilly is stockpiling orforglipron pills ahead of FDA approval. Explore the risks, rewards, and why investors are paying close attention to this launch.
What Chainsaw Man’s box office win reveals about the future of anime theatrical releases
Chainsaw Man: The Movie – Reze Arc claims the No. 1 spot with a $17.3M U.S. debut. Explore the box office impact, industry context, and what this means for anime films.